ClinicalTrials.gg
Not yet recruitingNCT06376812Updated Nov 10, 2026

No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women

An interventional study of Physical activity intervention in Elevated Blood Pressure and Perimenopause, sponsored by The University of Texas Medical Branch, Galveston. Not yet recruiting at 1 site in United States. Open to female participants aged 45 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by The University of Texas Medical Branch, Galveston · Not applicable, Interventional, and Prevention

How we know

Updated Nov 10, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
45 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 2,032 studies in Hypertension with a site in United States — 268 open to participants now, 369 under way, 16 of them phase 3. Hypertension · United States.

Planned enrollment
1,254th of 1,780
40 · median 100
Started
2027
with 17 others
No phase
1,072 of 2,032
168 open now
Primary completion
2029-01
later than 301 of 367 live
Registered
1,787th of 2,032
by date

Among the 2,032 studies in Hypertension with a site in United States, this one is the 1,254th largest by planned enrollment of the 1,780 interventional ones that give a count, is one of 18 that started in 2027, is one of 1,072 with no phase, reaches primary completion later than 301 of the 367 other live ones, and was the 1,787th registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

268 of the 2,032 studies in Hypertension with a site in United States are open now. Recruiting first, the newest first:

263 more — sign in →

All 268 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 45 Years to 50 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 2,032 studies in Hypertension with a site in United States, or all of them as a file.
02

Study summary

This study will test the effects of a physical activity intervention among midlife Hispanic women.

Read the detailed description

The menopausal transition in midlife is a critical juncture where women experience life transitions and adverse physiological and psychological changes that increase the risk for hypertension and cardiovascular diseases in later life. Physical activity improves blood pressure, biomarkers of hypertension, sleep, mood, and well-being; however, Hispanic women meet physical activity recommendations at lower levels than non-Hispanic White women. The investigator will examine the feasibility of the physical activity intervention among sedentary midlife Hispanic women in the menopausal transition with elevated blood pressure, exploring changes in physical activity and health.

03

Conditions studied

  • Elevated Blood Pressure
  • Perimenopause

Keywords

  • Physical activity
  • Women's health
  • Minority health
  • Behavior change
  • Hypertension prevention
04

Who can participate

Ages eligible
45 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Female
  2. Hispanic by self-report
  3. Able to speak and read English
  4. Sedentary
  5. Age 45-50
  6. Diagnosed with elevated blood pressure or objectively measured systolic blood pressure 120-139 mmHg and/or diastolic blood pressure 80-89 mmHg averaged from ≥ 2 measures on ≥ 2 outpatient visits
  7. Symptoms consistent with the menopause transition (persistent difference of ≥7 days in the length of consecutive cycles; persistence is defined as recurrence within 10 cycles of the first variable length cycle)
  8. Apparently healthy
  9. Self-reported ability to engage in moderate intensity physical activity
  10. Access to a smart device that is compatible with a Fitbit application

Exclusion criteria

Exclusion Criteria:

  1. Self-reported physical activity of ≥150 minutes per week
  2. Answered yes to any question on the Physical Activity Readiness (PAR-Q+) questionnaire
  3. (12-months without a menstrual cycle)
  4. Diagnosed hypertension
  5. Cardiovascular, respiratory, neurological, renal, endocrine, gastrointestinal and/or psychiatric diseases, or any cancers
  6. Previous hysterectomy, oophorectomy, and/or uterine ablation
  7. Medication to treat hypertension, elevated glucose, cholesterol, depression, anxiety, and insomnia
  8. Hormonal medication via any route or implants
  9. Tamoxifen
  10. Pregnant, planning to become pregnant, or breastfeeding
  11. Planning to move out of the Galveston/Houston area in the next 18 months
  12. Current participation in another physical activity study or program
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Physical activity intervention

    Multi-level intervention to increase physical activity

    Behavioral: Physical activity intervention

Interventions

  • BehavioralPhysical activity intervention

    Physical activity

06

What researchers measure

Primary outcomes

  1. Days the activity monitor was worn

    Objectively measured days the wearable activity monitor was worn during the intervention period

    Time frame: Baseline to 6-months

Secondary outcomes

  1. Physical activity as measured by minutes of moderate-vigorous intensity physical activity at 6 months

    Mean daily minutes of moderate-vigorous intensity physical activity taken from accelerometers for a 7 day period

    Time frame: Baseline to 6-months

  2. Physical activity as measured by minutes of moderate-vigorous intensity physical activity at 6 months

    Mean daily minutes of moderate-vigorous intensity physical activity taken from accelerometers for a 7 day period

    Time frame: Baseline to 12-months

  3. Physical activity as measured by minutes of moderate intensity physical activity at 6 months

    Mean daily minutes of moderate intensity physical activity taken from accelerometers for a 7 day period

    Time frame: Baseline to 6-months

  4. Physical activity as measured by minutes of moderate intensity physical activity at 6 months

    Mean daily minutes of moderate intensity physical activity taken from accelerometers for a 7 day period

    Time frame: Baseline to 12-months

  5. Physical activity as measured by minutes of vigorous intensity physical activity at 6 months

    Mean daily minutes of vigorous intensity physical activity taken from accelerometers for a 7 day period

    Time frame: Baseline to 6-months

  6. Physical activity as measured by minutes of vigorous intensity physical activity at 6 months

    Mean daily minutes of vigorous intensity physical activity taken from accelerometers for a 7 day period

    Time frame: Baseline to 12-months

  7. Physical activity as measured by minutes of light intensity physical activity at 6 months

    Mean daily minutes of light intensity physical activity taken from accelerometers for a 7 day period

    Time frame: Baseline to 6-months

  8. Physical activity as measured by minutes of light intensity physical activity at 6 months

    Mean daily minutes of light intensity physical activity taken from accelerometers for a 7 day period

    Time frame: Baseline to 12-months

  9. Physical activity as measured by minutes of total physical activity at 6 months

    Mean daily minutes of total physical activity taken from accelerometers for a 7 day period

    Time frame: Baseline to 6-months

  10. Physical activity as measured by minutes of total physical activity at 6 months

    Mean daily minutes of total physical activity taken from accelerometers for a 7 day period

    Time frame: Baseline to 12-months

  11. Systolic blood pressure

    Change in systolic blood pressure (mmHg)

    Time frame: Baseline to 6-months

  12. Systolic blood pressure

    Change in systolic blood pressure (mmHg)

    Time frame: Baseline to 12-months

  13. Diastolic blood pressure

    Change in diastolic blood pressure (mmHg)

    Time frame: Baseline to 6-months

  14. Diastolic blood pressure

    Change in diastolic blood pressure (mmHg)

    Time frame: Baseline to 12-months

Other outcomes

  1. Abdominal circumference

    Change in abdominal circumference (cm)

    Time frame: Baseline to 6-months

  2. Abdominal circumference

    Change in abdominal circumference (cm)

    Time frame: Baseline to 12-months

  3. Body mass index

    Change in body mass index (kg/m2)

    Time frame: Baseline to 6-months

  4. Body mass index

    Change in body mass index (kg/m2)

    Time frame: Baseline to 12-months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The research data from this project will be deposited with a service of the Inter-university Consortium for Political and Social Research (ICPSR), openICPSR, to ensure that the research community has long-term access to the data.

Supporting information: Study protocol, Statistical analysis plan

Time frame: We agree to deposit and/or make available our data upon completion of the clinical trial and acceptance of the data for publication. Data will be stored in the repository for at least 3 years, as required by federal retention guidelines.

Access criteria: Data will be shared via openICPSR as open access.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2027; primary completion for Jan 2029, 21 months later.

Of 1,407 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 21 months is close to that.

Counting every sponsor, half of 1,502 studies reached it within 23 months; a quarter within 10 and three quarters within 42.

Start moved once since we started tracking on Sep 25, 2026: Jan 2027 → Apr 2027, on Nov 10, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 16, 2024
First posted
Apr 19, 2024
StartEst.
Apr 20, 2027was Jan 2027
Primary completionEst.
Jan 2029
CompletionEst.
Jan 2029
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jan 20, 2027→Apr 20, 2027
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Start date Jan 20, 2027→Apr 20, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06376812
Responsible party
Sponsor
First posted
Apr 19, 2024
Start date
Apr 20, 2027 (estimated)
Primary completion
Jan 2029 (estimated)
Completion
Jan 2029 (estimated)
Last update
Nov 10, 2026

Study contacts

Lisa Thibodeaux, BSN, RNC-OB
Contact
lbthibod@utmb.edu
409-747-1756
Elizabeth Lorenzo, PhD, RN
principal investigator · University of Texas

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion